Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Pharmaceuticals distributor MPharma increased its funding to more than $38m in a round that included Dompe Holdings.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

University of Minnesota has invested in UBC spinout AbCellera's series B round that also included Eli Lilly.

Existing investor Novartis has committed to a $10m private placement alongside the IPO, in which the fibrosis therapy developer, based on UCSF research, is set to raise up to $96m.

A year after collecting $200m in series A funding, BGI gene sequencing spinoff MGI Tech has closed a $1bn series B round co-led by IDG Capital and CPE Capital.

Eli Lilly invested in AbCellera's series B round shortly after agreeing a research and collaboration licensing deal with the drug discovery technology provider.

Existing investor Novartis has committed to a $10m private placement alongside the IPO, in which the fibrosis therapy developer is set to raise up to $96m.

Axovant's seizure treatment spinoff has closed its series A round having received more than $133m in equity funding and $74.5m in project financing.

Eli Lilly, EMS, Takeda and ST Pharm are in line for exits after muscle disease therapy developer Avidity filed for a $100m initial public offering.